About Us


We are a group of like-minded material scientists, biomedical engineers, clinicians and regulatory specialists who believe in driving medical innovation using proprietary biomaterials. Our material technologies are designed for medical devices used in minimally invasive surgical procedures for General Surgery and ENT as adhesion prevention products, organ retraction products and hemostatic products.

Leveraging on our proprietary intellectual properties, we are expanding our core technologies vertically to lower risk products such as nasal splint and horizontally on higher risk products such as adhesion barrier for thyroidectomy. The application horizon of our core technologies is limitless as we continue to identify new unmet needs in the various clinical space.


Our Partners

Being a very new medtech startup based in Singapore, Sporogenics is very honored to be among the 20 companies selected for MedTech Innovator (MTI) Asia Pacific 2020 cohort. Under the MTI program, Sporogenics is indeed very privileged to be mentored by Olympus Medical, Johnson and Johnson and Oliver Healthcare Packaging.

Sporogenics is always pushing for scientific innovations and we are glad to be able to work together with our overseas and local academic partners such as School of Medicine, University of Tufts, US and Seoul National University Hospital.

Higher Efficacy

Multi-faceted clinical needs addressed by multifactorial approach.


Our devotion to sustainable solutions to improve clinical outcomes.


Unlocking nature’s potential to improve quality of life

Scroll to Top